drugset / Trial / NCT06816719
To Evaluate the Safety and PK Characteristics in Healthy Volunteers-JW24107
RandomizedCrossoverOpen-labelOther
Summary
The objective is to evaluate the safety and pharmacokinetic characteristics after co-administration of JW0106 and C2101 and administration of JW0107 in healthy volunteers under fasting conditions.
Timeline
- Start
- 2024-09-02
- Primary completion
- 2024-11-02
- Completion
- 2024-11-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | C2101 | Unknown | 1 unknown | Oral |
| Subject | JW0106 | Unknown | 1 unknown | Oral |
| Subject | JW0107 | Unknown | 1 unknown | Oral |
Indications
No indication recorded.